3750
S. Tanimori et al. / Tetrahedron 59 (2003) 3745–3751
4.2.6. 3-((1S,2R)-2-Hydroxy-1-methyl-2-phenylethyl)-5-
vinyl-1,3-oxazolidin-2-one (2f). A 1:1 mixture of dia-
stereomers. Yield: 57%. Colorless solid. Rf¼0.32
(hexane/EtOAc¼3:1). IR (KBr): 3411, 2939, 1720, 1448,
45.5, 51.4, 73.9, 118.6, 126.8, 127.7, 128.5, 134.4, 139.3,
157.1. EI MS m/z (%) 217 (56, Mþ), 202 (36), 163 (24), 153
(21), 131 (46), 105 (100), 77 (69). HRMS calcd for
C17H22O2N2 (Mþ) 217.1103; found 217.1074. More polar
isomer (10S,5S)-2h: colorless liquid. Rf¼0.33 (hexane/
EtOAc¼2.5:1). [a]D22¼265.8 (c 1.1, CHCl3). 1H NMR
(270 MHz, CDCl3): d 1.58 (1H, d, J¼7.3 Hz), 2.85 (1H, dd,
J¼7.6, 8.5 Hz), 3.61 (1H, dd, J¼7.6, 8.5 Hz), 4.90 (1H, dt,
J¼7.3, 7.6 Hz), 5.22 (1H, q, J¼7.3 Hz), 5.23 (1H, d,
J¼10.7 Hz), 5.35 (1H, d, J¼17.1 Hz), 5.75 (1H, ddd, J¼7.6,
10.4, 17.1 Hz), 7.14–7.48 (5H, m). 13C NMR (67.5 MHz,
CDCl3): d 16.5, 45.3, 51.2, 73.9, 118.5, 126.8, 127.7, 128.5,
134.3, 139.1, 157.1.
1
1260, 998, 762, 702 cm21. H NMR (270 MHz, CDCl3): d
1.16 (3H, d, J¼7.0 Hz), 1.18 (3H, d, J¼7.0 Hz), 3.15 (1H,
dd, J¼7.3, 8.9 Hz), 3.27 (1H, dd, J¼6.7, 8.9 Hz), 3.64 (1H,
dt, J¼8.9, 12.5 Hz), 3.89–4.04 (1H, m), 4.65–4.89 (1H, m),
4.93 (1H, dd, J¼4.0, 5.8 Hz), 5.24–5.39 (2H, m), 5.70–5.85
(1H, m), 7.18–7.43 (5H, m). 13C NMR (67.5 MHz, CDCl3):
d 157.7, 141.2, 141.1, 134.3, 134.2, 128.2, 127.6, 126.0,
125.9, 118.7, 118.6, 76.5, 76.4, 74.5, 74.4, 55.1, 48.3, 48.1,
11.6, 11.4. EI MS m/z (%) 247 (2, Mþ), 190 (11), 118 (44),
105 (100), 91 (17), 77 (16), 56 (25). HRMS calcd for
C17H22O2N2 (Mþ) 247.2955; found 247.2941.
(10R, 5S)-2i: Rf¼0.43 (hexane/EtOAc¼2.5:1). [a]2D2¼þ37.3
(c 1.84, CHCl3).
4.2.7. 3-[(1R,2S)-2-Hydroxyindanyl]-5-vinyl-1,3-oxazoli-
din-2-one (2g). Yield: 41% (less polar 21%, more polar
20%). Rf¼0.17 and 0.29 (hexane/EtOAc¼2:1). Less polar:
colorless needles. Mp. 127–1288C. Rf¼0.29 (hexane/
EtOAc¼2:1). [a]2D2¼247.1 (c 1.2, CHCl3). IR (neat):
(10R,5R)-2i: Rf¼0.33 (hexane/EtOAc¼2.5:1). [a]2D2¼þ78.4
(c 1.84, CHCl3).
4.2.9. (10S, 5S)-5-Hydroxymethyl-3-(1-phenylethyl)oxa-
zolidin-2-one (19). To a solution of alkene (10S,5S)-2h
(50 mg, 0.23 mmol) in THF (4.2 mL) stirred under nitrogen
atmosphere was added 1% aqueous osmium tetraoxide
solution (1 mL). Then, sodium periodate (0.25 g,
1.15 mmol) in water (1.4 mL) was added to the solution
and the resulting mixture was stirred for 2 h.
1
3419, 2916, 1731, 1428, 1255, 757, 742 cm21. H NMR
(270 MHz, CDCl3): d 2.91 (1H, dd, J¼6.1, 16.5 Hz), 3.21–
3.42 (3H, m), 4.79–4.92 (2H, m), 5.43–5.23 (3H, m), 5.94
(1H, ddd, J¼7.0, 10.4, 17.1 Hz), 7.13–7.37 (4H, m). 13C
NMR (67.5 MHz, CDCl3): d 39.9, 48.6, 60.1, 73.0, 75.4,
119.2, 125.3, 125.7, 127.3, 129.0, 134.4, 137.1, 140.7,
158.6. EI MS m/z (%) 245 (2, Mþ), 188 (33), 176 (28), 144
(100), 115 (92), 103 (13), 91 (13), 77 (13), 56 (25). HRMS
calcd for C17H22O2N2 (Mþ) 245.2796; found 245.2818.
More polar: colorless liquid. Rf¼0.17 (hexane/EtOAc¼2:1).
[a]2D2¼þ36.6 (c 1.3, CHCl3). 1H NMR (270 MHz, CDCl3):
d 2.93 (1H, dd, J¼5.8, 16.8 Hz), 3.00 (1H, dd, J¼6.4,
8.9 Hz), 3.28 (1H, dd, J¼7.0, 16.8 Hz), 3.75 (1H, t,
J¼8.9 Hz), 4.83 (1H, dt, J¼5.8, 6.4 Hz), 4.99 (1H, dd,
J¼6.4, 15.3 Hz), 5.21–5.42 (3H, m), 5.84 (1H, ddd, J¼6.4,
10.4, 17.1 Hz), 7.13–7.38 (4H, m). 13C NMR (67.5 MHz,
CDCl3): d 39.8, 48.4, 60.2, 72.8, 74.5, 118.5, 125.3, 125.5,
127.2, 128.9, 134.4, 136.9, 140.7, 158.6.
The above mixture was diluted with ethanol (1 mL), sodium
borohydride (4.4 mg, 0.12 mmol) was added at 08C, and the
resulting mixture was stirred for 2.5 h at room temperature.
Water (5 mL) was added and the mixture was extracted with
ether. The combined organic phase was washed with water
and brine, dried over MgSO4, filtered, and evaporated in
vacuo to yield crude alcohol, which was purified by silica
gel chromatography (hexane/EtOAc¼1:2) to give pure
alcohol 19 (31 mg, 62%) as a white solid.
Yield: 62% (2 steps). Rf¼0.6 (EtOAc). IR (KBr): 3392,
1
2897, 1733, 1444, 1406, 1257, 1074, 760 cm21. H NMR
4.2.8. 3-(1-Phenyleth-1-yl)-5-vinyl-1,3-oxazolidin-2-one
(2h and 2i). A degassed solution of 2-butenylene dicarbo-
nate 1 (50 mg, 0.24 mmol), (S)-(2)-phenethylamine (0.046
mL, 0.36 mmol), Pd2(dba)3·CHCl3 (1.2 mg, 0.0012 mmol,
0.5 mol%), and DPPFOAc (2.0 mg, 0.0031 mmol,
1.3 mol%) in THF (1 ml) was stirred at 408C for 20 h. The
mixture was filtered through a pad of silica gel and the
solvent evaporated in vacuo. The residue was then subjected
to0 preparative TLC (50% EtOAc in hexane) to produce
(1 S,5R)-2h (29.2 mg, 55%) and (10S,5S)-2h (6 mg, 12%) as
an oil.
(270 MHz, CDCl3): d 1.5 (3H, d, J¼7.3 Hz, CH3), 3.15 (1H,
t, J¼8.5, 9.2 Hz, one of CH2N), 3.4 (1H, dd, J¼8.5, 9.2 Hz,
one of CH2N), 3.7 (2H, m, CH2OH), 3.8 (1H, br s, OH),
4.4–4.6 (1H, m, CH–O), 5.20 (1H, q, J¼7.0 Hz, NCH2Ph),
7.2–7.3 (5H, m, ArH). 13C NMR (67.5 MHz, CDCl3): d
16.2, 41.2, 51.5, 63.1, 73.4, 126.7, 127.8, 128.6, 139.3,
157.2. [a]2D9¼230.6 (c 0.5, CHCl3) (lit.7228.4 (c 5,
CHCl3)). Mp. 1018C (lit.7 1028C).
References
Yield: 67% (less polar 55%, more polar 12%). Less polar
isomer (10S,5R)-2h: colorless liquid. Rf¼0.43 (hexane/
EtOAc¼2.5:1). [a]2D2¼234.0 (c 0.75, CHCl3). IR (KBr):
2980, 1750, 1420, 1244, 1024, 703 cm21 1H NMR
.
1. Tanimori, S.; Kirihata, M. Tetrahedron Lett. 2000, 41,
6785–6788.
2. (a) Mai, A.; Artico, M.; Esposito, M.; Sbardella, G.; Massa, S.;
(270 MHz, CDCl3): d 1.56 (3H, d, J¼7.3 Hz, –CH3), 3.20
(1H, t, J¼8.6 Hz, one of CH2N), 3.30 (1H, t, J¼8.6 Hz, one
of CH2N), 4.82 (1H, dd, J¼7.3, 7.6 Hz, HC–O), 5.22 (1H,
q, J¼7.3 Hz, –CHMePh), 5.30 (1H, d, J¼10.6 Hz,
CHvCHH (cis)), 5.39 (1H, d, J¼17.2 Hz, CHvCHH
(trans)), 5.89 (1H, ddd, J¼7.6, 10.2, 17.2 Hz, CHvCH2),
7.20–7.43 (5H, m). 13C NMR (67.5 MHz, CDCl3): d 16.2,
`
Befani, O.; Turini, P.; Giovannini, V.; Mondavı, B. J. Med.
Chem. 2002, 45, 1180–1183. (b) Selvakumar, N.; Srinivas, D.;
Khera, M. K.; Kumar, M. S.; Mamidi, R. N. V. S.; Sarnaik, H.;
Charavaryamath, C.; Rao, B. S.; Raheem, M. A.; Das, J.; Iqbal,
J.; Rajagopalan, R. J. Med. Chem. 2002, 45, 3953–3962, and
references cited therein.
3. For recent examples, see: (a) Holden, K. G.; Mattson, M. N.;